What is Assembly Biosciences's revenue?

Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.

Is Assembly Biosciences profitable?

Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.

What is Assembly Biosciences's earnings per share?

Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.

Where does Assembly Biosciences's income statement data come from?

Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Assembly Biosciences ASMB Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$72.3M+154%	$28.52M+298%	$7.16M—	$0—
Research and development	$64.81M+15.9%	$55.93M+14.4%	$48.9M-30.1%	$69.98M+2.1%
General and administrative	$19.61M+8.9%	$18.01M-21.4%	$22.91M-5.1%	$24.13M-16.1%
Other operating expenses	$84.42M+14.2%	$73.94M+3.0%	$71.81M-23.7%	$94.11M-32.3%
Total operating expenses	$84.42M+14.2%	$73.94M+3.0%	$71.81M-23.7%	$94.11M-32.3%
Operating income	——	-$45.42M+29.7%	-$64.65M+31.3%	-$94.11M+29.1%
Interest income	$6M+7.6%	$5.57M+61.5%	$3.45M+238%	$1.02M+238%
Other income (expense), net	$6M+7.6%	$5.57M+61.5%	$3.45M+238%	$1.02M+238%
Net income	——	-$40.18M+34.4%	-$61.23M+34.2%	-$93.09M+28.3%
Diluted earnings per share	——	-$6.72+49.9%	-$13.40+42.0%	-$23.09-665%
Basic earnings per share	——	-$6.72+49.9%	-$13.40+42.0%	-$23.09-670%
Weighted-average shares, diluted	39.1M+66.3%	23.5M+33.7%	17.6M-88.2%	148.9M-13.1%
Weighted-average shares, basic	39.1M+66.3%	23.5M+33.7%	17.6M-88.2%	148.9M—
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	——	-$40.31M+33.4%	-$60.51M+35.3%	-$93.48M+28.1%
Interest Income, Other	$6M+7.6%	$5.57M+61.5%	$3.45M+238%	$1.02M+238%
Net unrealized gains (losses) on securities still held	$170K+231%	-$130K-118%	$722K—	——
Revenue From Contract With Customer Excluding Assessed Tax	$72.3M+154%	$28.52M—	——	——
EBIT	——	-$45.42M+29.7%	-$64.65M+31.3%	-$94.11M+29.1%
EBITDA	——	-$45.29M+29.4%	-$64.2M+31.4%	-$93.62M+29.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Assembly Biosciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's revenue?: Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
Is Assembly Biosciences profitable?: Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
What is Assembly Biosciences's earnings per share?: Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
Where does Assembly Biosciences's income statement data come from?: Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.